Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
Pharmacology, Biochemistry, and Behavior|August 28, 2022
Group III metabotropic glutamate receptors as promising targets for neuroprotective therapy: Particular emphasis on the role of mGlu4 and mGlu7 receptorsHelena Domin
Progress in Neuro-Psychopharmacology & Biological Psychiatry|May 15, 2021
Neuropeptide Y Y2 and Y5 receptors as potential targets for neuroprotective and antidepressant therapies: Evidence from preclinical studiesHelena Domin
Neuroscience and Biobehavioral Reviews|June 10, 2024
The diverse role of corticotropin-releasing factor (CRF) and its CRF1 and CRF2 receptors under pathophysiological conditions: Insights into stress/anxiety, depression, and brain injury processesHelena Domin, Maria Śmiałowska
Pharmacological Reports : PR|September 30, 2024
mGlu4R, mGlu7R, and mGlu8R allosteric modulation for treating acute and chronic neurodegenerative disordersHelena Domin, Grzegorz Burnat
Pharmacological Reports : PR|January 16, 2007
Neuroprotective effects of MTEP, a selective mGluR5 antagonists and neuropeptide Y on the kainate-induced toxicity in primary neuronal culturesHelena Domin, Małgorzata Kajta, Maria Smiałowska
Neurochemistry International|January 11, 2015
Neuroprotective effects of the allosteric agonist of metabotropic glutamate receptor 7 AMN082 on oxygen-glucose deprivation- and kainate-induced neuronal cell deathHelena Domin, Danuta Jantas, Maria Śmiałowska
Neuropeptides|June 1, 2021
A role of noradrenergic receptors in anxiolytic-like effect of high CRF in the rat frontal cortexMaria Śmiałowska, Barbara Zięba, Helena Domin
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|November 30, 2006
The effect of intrahippocampal injection of group II and III metobotropic glutamate receptor agonists on anxiety; the role of neuropeptide YMaria Smiałowska, Joanna M Wierońska, Helena Domin, et al.
Pharmacological Reports : PR|October 18, 2011
Anxiolytic-like activity of MGS0039, a selective group II mGlu receptor antagonist, is serotonin- and GABA-dependentKatarzyna Stachowicz, Joanna Wierońska, Helena Domin, et al.
Psychopharmacology|December 16, 2016
Antidepressant-like activity of the neuropeptide Y Y5 receptor antagonist Lu AA33810: behavioral, molecular, and immunohistochemical evidenceHelena Domin, Bernadeta Szewczyk, Bartłomiej Pochwat, et al.
Pageof 4